ACB - Aurora Cannabis Inc


3.54
0.040   1.130%

Share volume: 538,465
Last Updated: 03-10-2026
Pharmaceutical Products/Medicinal Chemicals: 2.20%

PREVIOUS CLOSE
CHG
CHG%

$3.50
0.04
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
93%
Profitability 100%
Dept financing 50%
Liquidity 75%
Performance 100%
Performance
5 Days
0.85%
1 Month
2.91%
3 Months
-22.20%
6 Months
-28.19%
1 Year
-18.24%
2 Year
-36.04%
Key data
Stock price
$3.54
P/E Ratio 
N/A
DAY RANGE
$3.52 - $3.66
EPS 
N/A
52 WEEK RANGE
$3.28 - $6.66
52 WEEK CHANGE
-$19.55
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
06-20-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$675,410
AVERAGE 30 VOLUME 
$734,412
Company detail
CEO: Miguel Martin
Region: US
Website: auroramj.com
Employees: 1,340
IPO year: 2018
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; herb mills for using CanniMed herbal cannabis products.

Recent news